{"pmid":32459061,"title":"Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.","text":["Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.","BACKGROUND: The novel coronavirus 2019 (COVID-19) pandemic has changed health care, challenged by resource constraints and fears of transmission. We report the surgical practice pattern changes in a Head and Neck Surgery department of a tertiary cancer care center and discuss the issues surrounding multidisciplinary care during the pandemic. METHODS: We report data regarding outpatient visits, multidisciplinary treatment planning conference, surgical caseload, and modifications of oncologic therapy during this pandemic and compared this data to the same interval last year. RESULTS: We found a 46.7% decrease in outpatient visits and a 46.8% decrease in surgical caseload, compared to 2019. We discuss the factors involved in the decision-making process and perioperative considerations. CONCLUSIONS: Surgical practice patterns in head and neck oncologic surgery will continue to change with the evolving pandemic. Despite constraints, we strive to prioritize and balance the oncologic and safety needs of patients with head and neck cancer in the face of COVID-19.","Head Neck","Kiong, Kimberley L","Guo, Theresa","Yao, Christopher M K L","Gross, Neil D","Hanasono, Matthew M","Ferrarotto, Renata","Rosenthal, David I","Myers, Jeffrey N","Hanna, Ehab Y","Lai, Stephen Y","32459061"],"abstract":["BACKGROUND: The novel coronavirus 2019 (COVID-19) pandemic has changed health care, challenged by resource constraints and fears of transmission. We report the surgical practice pattern changes in a Head and Neck Surgery department of a tertiary cancer care center and discuss the issues surrounding multidisciplinary care during the pandemic. METHODS: We report data regarding outpatient visits, multidisciplinary treatment planning conference, surgical caseload, and modifications of oncologic therapy during this pandemic and compared this data to the same interval last year. RESULTS: We found a 46.7% decrease in outpatient visits and a 46.8% decrease in surgical caseload, compared to 2019. We discuss the factors involved in the decision-making process and perioperative considerations. CONCLUSIONS: Surgical practice patterns in head and neck oncologic surgery will continue to change with the evolving pandemic. Despite constraints, we strive to prioritize and balance the oncologic and safety needs of patients with head and neck cancer in the face of COVID-19."],"journal":"Head Neck","authors":["Kiong, Kimberley L","Guo, Theresa","Yao, Christopher M K L","Gross, Neil D","Hanasono, Matthew M","Ferrarotto, Renata","Rosenthal, David I","Myers, Jeffrey N","Hanna, Ehab Y","Lai, Stephen Y"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32459061","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/hed.26202","keywords":["sars-cov2","oncology","otolaryngology"],"topics":["Prevention"],"weight":1,"_version_":1667967698952257536,"score":9.490897,"similar":[{"pmid":32342541,"title":"Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","text":["Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability.","Head Neck","Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y","32342541"],"abstract":["BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability."],"journal":"Head Neck","authors":["Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342541","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26206","keywords":["sars-cov2","oncology","otolaryngology"],"topics":["Prevention"],"weight":1,"_version_":1666138495125553152,"score":505.8975},{"pmid":32330858,"pmcid":"PMC7136871","title":"Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.","text":["Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.","The COVID-19 pandemic demands reassessment of head and neck oncology treatment paradigms. Head and neck cancer (HNC) patients are generally at high-risk for COVID-19 infection and severe adverse outcomes. Further, there are new, multilevel COVID-19-specific risks to patients, surgeons, health care workers (HCWs), institutions and society. Urgent guidance in the delivery of safe, quality head and neck oncologic care is needed. Novel barriers to safe HNC surgery include: (1) imperfect presurgical screening for COVID-19; (2) prolonged SARS-CoV-2 aerosolization; (3) occurrence of multiple, potentially lengthy, aerosol generating procedures (AGPs) within a single surgery; (4) potential incompatibility of enhanced personal protective equipment (PPE) with routine operative equipment; (5) existential or anticipated PPE shortages. Additionally, novel, COVID-19-specific multilevel risks to HNC patients, HCWs and institutions, and society include: use of immunosuppressive therapy, nosocomial COVID-19 transmission, institutional COVID-19 outbreaks, and, at some locations, societal resource deficiencies requiring health care rationing. Traditional head and neck oncology doctrines require reassessment given the extraordinary COVID-19-specific risks of surgery. Emergent, comprehensive management of these novel, multilevel surgical risks are needed. Until these risks are managed, we temporarily favor nonsurgical therapy over surgery for most mucosal squamous cell carcinomas, wherein surgery and nonsurgical therapy are both first-line options. Where surgery is traditionally preferred, we recommend multidisciplinary evaluation of multilevel surgical-risks, discussion of possible alternative nonsurgical therapies and shared-decision-making with the patient. Where surgery remains indicated, we recommend judicious preoperative planning and development of COVID-19-specific perioperative protocols to maximize the safety and quality of surgical and oncologic care.","Oral Oncol","Day, Andrew T","Sher, David J","Lee, Rebecca C","Truelson, John M","Myers, Larry L","Sumer, Baran D","Stankova, Lenka","Tillman, Brittny N","Hughes, Randall S","Khan, Saad A","Gordin, Eli A","32330858"],"abstract":["The COVID-19 pandemic demands reassessment of head and neck oncology treatment paradigms. Head and neck cancer (HNC) patients are generally at high-risk for COVID-19 infection and severe adverse outcomes. Further, there are new, multilevel COVID-19-specific risks to patients, surgeons, health care workers (HCWs), institutions and society. Urgent guidance in the delivery of safe, quality head and neck oncologic care is needed. Novel barriers to safe HNC surgery include: (1) imperfect presurgical screening for COVID-19; (2) prolonged SARS-CoV-2 aerosolization; (3) occurrence of multiple, potentially lengthy, aerosol generating procedures (AGPs) within a single surgery; (4) potential incompatibility of enhanced personal protective equipment (PPE) with routine operative equipment; (5) existential or anticipated PPE shortages. Additionally, novel, COVID-19-specific multilevel risks to HNC patients, HCWs and institutions, and society include: use of immunosuppressive therapy, nosocomial COVID-19 transmission, institutional COVID-19 outbreaks, and, at some locations, societal resource deficiencies requiring health care rationing. Traditional head and neck oncology doctrines require reassessment given the extraordinary COVID-19-specific risks of surgery. Emergent, comprehensive management of these novel, multilevel surgical risks are needed. Until these risks are managed, we temporarily favor nonsurgical therapy over surgery for most mucosal squamous cell carcinomas, wherein surgery and nonsurgical therapy are both first-line options. Where surgery is traditionally preferred, we recommend multidisciplinary evaluation of multilevel surgical-risks, discussion of possible alternative nonsurgical therapies and shared-decision-making with the patient. Where surgery remains indicated, we recommend judicious preoperative planning and development of COVID-19-specific perioperative protocols to maximize the safety and quality of surgical and oncologic care."],"journal":"Oral Oncol","authors":["Day, Andrew T","Sher, David J","Lee, Rebecca C","Truelson, John M","Myers, Larry L","Sumer, Baran D","Stankova, Lenka","Tillman, Brittny N","Hughes, Randall S","Khan, Saad A","Gordin, Eli A"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330858","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.oraloncology.2020.104684","keywords":["covid-19 pandemic","head and neck cancer","head and neck oncology","mucosal squamous cell carcinoma","multilevel risk","risk stratification","sars-cov-2","surgical barriers","surgical risk","treatment paradigms"],"topics":["Prevention"],"weight":1,"_version_":1666138494701928448,"score":429.0209},{"pmid":32437032,"title":"Care in the time of coronavirus: Ethical considerations in head and neck oncology.","text":["Care in the time of coronavirus: Ethical considerations in head and neck oncology.","As COVID-19 continues to challenge the practice of head and neck oncology, clinicians are forced to make new decisions in the setting of the pandemic that impact the safety of their patients, their institutions, and themselves. The difficulty inherent in these decisions is compounded by potentially serious ramifications to the welfare of patients and health-care staff, amid a scarcity of data on which to base informed choices. This paper explores the risks of COVID-19 incurred while striving to uphold the standard of care in head and neck oncology. The ethical problems are assessed from the perspective of the patient with cancer, health-care provider, and other patients within the health-care system. While no single management algorithm for head and neck cancer can be universally implemented, a detailed examination of these issues is necessary to formulate ethically sound treatment strategies.","Head Neck","Gordin, Eli A","Day, Andrew","Stankova, Lenka","Heitman, Elizabeth","Sadler, John","32437032"],"abstract":["As COVID-19 continues to challenge the practice of head and neck oncology, clinicians are forced to make new decisions in the setting of the pandemic that impact the safety of their patients, their institutions, and themselves. The difficulty inherent in these decisions is compounded by potentially serious ramifications to the welfare of patients and health-care staff, amid a scarcity of data on which to base informed choices. This paper explores the risks of COVID-19 incurred while striving to uphold the standard of care in head and neck oncology. The ethical problems are assessed from the perspective of the patient with cancer, health-care provider, and other patients within the health-care system. While no single management algorithm for head and neck cancer can be universally implemented, a detailed examination of these issues is necessary to formulate ethically sound treatment strategies."],"journal":"Head Neck","authors":["Gordin, Eli A","Day, Andrew","Stankova, Lenka","Heitman, Elizabeth","Sadler, John"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437032","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26272","keywords":["covid-19","cancer","ethics","head and neck","oncology"],"weight":0,"_version_":1667521393588174848,"score":421.60388},{"pmid":32427410,"title":"Head and neck oncologic surgery in the COVID-19 pandemic: Our experience in a deep south tertiary care center.","text":["Head and neck oncologic surgery in the COVID-19 pandemic: Our experience in a deep south tertiary care center.","INTRODUCTION: The ongoing worldwide pandemic due to COVID-19 has forced drastic changes on the daily lives of the global population. This is most notable within the health care sector. The current paper outlines the response of the head and neck oncologic surgery (HNS) division within our academic otolaryngology department in the state of Alabama. METHODS: Data with regard to case numbers and types were obtained during the pandemic and compared with time matched data. Our overall approach to managing previously scheduled and new cases, personal protective equipment (PPE) utilization, outpatient clinic, and resident involvement is summarized. DISCUSSION: Our HNS division saw a 55% reduction in surgical volume during the peak of the COVID-19 pandemic. We feel that an early and cohesive strategy to triaging surgical cases, PPE usage, and minimizing exposure of personnel is essential to providing care for HNS patients during this pandemic.","Head Neck","Morrison, Daniel R","Gentile, Christopher","McCammon, Susan","Buczek, Erin","32427410"],"abstract":["INTRODUCTION: The ongoing worldwide pandemic due to COVID-19 has forced drastic changes on the daily lives of the global population. This is most notable within the health care sector. The current paper outlines the response of the head and neck oncologic surgery (HNS) division within our academic otolaryngology department in the state of Alabama. METHODS: Data with regard to case numbers and types were obtained during the pandemic and compared with time matched data. Our overall approach to managing previously scheduled and new cases, personal protective equipment (PPE) utilization, outpatient clinic, and resident involvement is summarized. DISCUSSION: Our HNS division saw a 55% reduction in surgical volume during the peak of the COVID-19 pandemic. We feel that an early and cohesive strategy to triaging surgical cases, PPE usage, and minimizing exposure of personnel is essential to providing care for HNS patients during this pandemic."],"journal":"Head Neck","authors":["Morrison, Daniel R","Gentile, Christopher","McCammon, Susan","Buczek, Erin"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427410","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26262","keywords":["covid-19","coronavirus","head and neck","oncology","otolaryngology"],"locations":["Alabama"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1667252837679104002,"score":412.57513},{"pmid":32357380,"title":"Changes in Head and Neck Oncologic Practice During the COVID-19 Pandemic.","text":["Changes in Head and Neck Oncologic Practice During the COVID-19 Pandemic.","INTRODUCTION: The COVID-19 pandemic has raised controversies regarding safe and effective care of head and neck cancer patients. It is unknown how much the pandemic has changed surgeon practice. METHODS: A questionnaire was distributed to head and neck surgeons assessing opinions related to treatment and concerns for the safety of patients, self, family, and staff. RESULTS: A total of 67 head and neck surgeons responded during the study period. Surgeons continued to recommend primary surgical treatment for oral cavity cancers. Respondents were more likely to consider non-surgical therapy for patients with early glottic cancers and HPV-mediated oropharynx cancer. Surgeons were least likely to be concerned for their own health and safety and had the greatest concern for their resident trainees. CONCLUSIONS: This study highlights differences in the willingness of head and neck surgeons to delay surgery or alter plans during times when hospital resources are scarce and risk is high. This article is protected by copyright. All rights reserved.","Head Neck","Brody, Robert M","Albergotti, W Greer","Shimunov, David","Nicolli, Elizabeth","Harris, Brianna N","Bur, Andres M","32357380"],"abstract":["INTRODUCTION: The COVID-19 pandemic has raised controversies regarding safe and effective care of head and neck cancer patients. It is unknown how much the pandemic has changed surgeon practice. METHODS: A questionnaire was distributed to head and neck surgeons assessing opinions related to treatment and concerns for the safety of patients, self, family, and staff. RESULTS: A total of 67 head and neck surgeons responded during the study period. Surgeons continued to recommend primary surgical treatment for oral cavity cancers. Respondents were more likely to consider non-surgical therapy for patients with early glottic cancers and HPV-mediated oropharynx cancer. Surgeons were least likely to be concerned for their own health and safety and had the greatest concern for their resident trainees. CONCLUSIONS: This study highlights differences in the willingness of head and neck surgeons to delay surgery or alter plans during times when hospital resources are scarce and risk is high. This article is protected by copyright. All rights reserved."],"journal":"Head Neck","authors":["Brody, Robert M","Albergotti, W Greer","Shimunov, David","Nicolli, Elizabeth","Harris, Brianna N","Bur, Andres M"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32357380","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26233","keywords":["covid-19","coronavirus","head and neck cancer","sars-cov-2","treatment delays","wellness"],"locations":["Head"],"topics":["Prevention"],"weight":1,"_version_":1666138495288082432,"score":397.5415}]}